skip to main content

Survival after Radiofrequency Ablation in 122 Patients with Inoperable Colorectal Lung Metastases

Gillams, Alice ; Khan, Zahid ; Osborn, Peter ; Lees, William

Cardiovascular and Interventional Radiology, 15 June 2013, Vol.36(3) [Peer Reviewed Journal]

Full text available

Citations Cited by
  • Title:
    Survival after Radiofrequency Ablation in 122 Patients with Inoperable Colorectal Lung Metastases
  • Author: Gillams, Alice ; Khan, Zahid ; Osborn, Peter ; Lees, William
  • Subjects: Radiology And Nuclear Medicine ; Ablation ; Anesthesia ; Biomedical Radiography ; Chemotherapy ; Images ; Liver ; Lungs ; Metastases ; Neoplasms ; Patients ; Radiowave Radiation ; Medicine
  • Is Part Of: Cardiovascular and Interventional Radiology, 15 June 2013, Vol.36(3)
  • Description: Purpose. To analyze the factors associated with favorable survival in patients with inoperable colorectal lung metastases treated with percutaneous image-guided radiofrequency ablation. Methods. Between 2002 and 2011, a total of 398 metastases were ablated in 122 patients (87 male, median age 68 years, range 29-90 years) at 256 procedures. Percutaneous CT-guided cool-tip radiofrequency ablation was performed under sedation/general anesthesia. Maximum tumor size, number of tumors ablated, number of procedures, concurrent/prior liver ablation, previous liver or lung resection, systemic chemotherapy, disease-free interval from primary resection to lung metastasis, and survival from first ablation were recorded prospectively. Kaplan-Meier analysis was performed, and factors were compared by log rank test. Results. The initial number of metastases ablated was 2.3 (range 1-8); the total number was 3.3 (range 1-15). The maximum tumor diameter was 1.7 (range 0.5-4) cm, and the number of procedures was 2 (range 1-10). The major complication rate was 3.9 %. Overall median and 3-year survival rate were 41 months and 57 %. Survival was better in patients with smaller tumors-a median of 51 months, with 3-year survival of 64 % for tumors 2 cm or smaller versus 31 months and 44 % for tumors 2.1-4 cm (p = 0.08). The number of metastases ablated and whether the tumors were unilateral or bilateral did not affect survival. The presence of treated liver metastases, systemic chemotherapy, or prior lung resection did not affect survival. Conclusion. Three-year survival of 57 % in patients with inoperable colorectal lung metastases is better than would be expected with chemotherapy alone. Patients with inoperable but small-volume colorectal lung metastases should be referred for ablation.
  • Language: English
  • Identifier: ISSN: 0174-1551 ; E-ISSN: 1432-086X ; DOI: 10.1007/S00270-012-0500-3
  • Source: SciTech Connect (U.S. Dept. of Energy - Office of Scientific and Technical Information)

Searching Remote Databases, Please Wait